Stocks in Focus : Arrowhead Research (NASDAQ:ARWR), Sonus Networks (NASDAQ:SONS), RGC (NASDAQ:RGCO), American Electric Power Co., Inc. (NYSE:AEP), American Science (NASDAQ:ASEI)

Arrowhead Research Corp. (NASDAQ:ARWR) on Aug. 12 announced financial results for its fiscal 2014 third quarter ended June 30, 2014 and provided an update on the Phase 2a study of ARC-520, its RNAi-based candidate for the treatment of chronic hepatitis B infection. Net loss attributable to Arrowhead for the quarter was $11.6 million, or $0.22 per share based on 51.9 million weighted average shares outstanding. … Continue reading Stocks in Focus : Arrowhead Research (NASDAQ:ARWR), Sonus Networks (NASDAQ:SONS), RGC (NASDAQ:RGCO), American Electric Power Co., Inc. (NYSE:AEP), American Science (NASDAQ:ASEI)

Kristen Barton09/0309/03

Small Cap Bullish Stocks; Empire Resorts (NASDAQ:NYNY), Altisource Asset Management (NYSEMKT:AAMC), Tennant Company (NYSE:TNC), ExOne (NASDAQ:XONE), Arrowhead Research (NASDAQ:ARWR)

Empire Resorts Inc (NASDAQ:NYNY)’s addition to the Russell 2000 and Russell 3000 Indexes is part of Russell Investments’ annual index reconstitution process that is done to maintain a true representation of global equity markets, capitalization and style. Russell posted the annual list of preliminary index additions, which includes Empire, on www.russell.com, on June 13, 2014. Russell will provide updates to the list of additions and … Continue reading Small Cap Bullish Stocks; Empire Resorts (NASDAQ:NYNY), Altisource Asset Management (NYSEMKT:AAMC), Tennant Company (NYSE:TNC), ExOne (NASDAQ:XONE), Arrowhead Research (NASDAQ:ARWR)

Jayne Crisman06/2706/27

Biotech Bearish Stocks: Zalicus Inc (NASDAQ:ZLCS), Stemline Therapeutics Inc (NASDAQ:STML), Agenus Inc (NASDAQ:AGEN), Arrowhead Research Corp (NASDAQ:ARWR), Ultragenyx Pharmaceutical Inc (NASDAQ:RARE)

Zalicus Inc (NASDAQ:ZLCS) on June 18 announced that it has licensed its Sodium Channel Modulator program, including intellectual property and related pipeline assets, to AnaBios Corporation in exchange for clinical milestone payments and royalties on potential future sales. Under the terms of the agreement Zalicus will be eligible to receive up to $17.2 million in clinical and regulatory milestone payments and up to 12% of … Continue reading Biotech Bearish Stocks: Zalicus Inc (NASDAQ:ZLCS), Stemline Therapeutics Inc (NASDAQ:STML), Agenus Inc (NASDAQ:AGEN), Arrowhead Research Corp (NASDAQ:ARWR), Ultragenyx Pharmaceutical Inc (NASDAQ:RARE)

Kevin Long06/2006/20

Biotech Active Stocks: Arrowhead Research (NASDAQ:ARWR), Gilead Sciences (NASDAQ:GILD), Novavax (NASDAQ:NVAX), MannKind Corporation (NASDAQ:MNKD)

Arrowhead Research Corp (NASDAQ:ARWR) stock had its “buy” rating reaffirmed by stock analysts at Deutsche Bank in a report issued on Monday, American Banking News.com reports. Arrowhead Research Corp (NASDAQ:ARWR) stock performance was -16.09% in last session and finished the day at $17.37. Traded volume was 7.56million shares in the last session and the average volume of the stock remained 1.44million shares. The beta of … Continue reading Biotech Active Stocks: Arrowhead Research (NASDAQ:ARWR), Gilead Sciences (NASDAQ:GILD), Novavax (NASDAQ:NVAX), MannKind Corporation (NASDAQ:MNKD)

Chris Lewis03/2503/25

Biotech Gainers: Arrowhead Research (NASDAQ:ARWR), DARA Biosciences (NASDAQ:DARA), Synthetic Biologics (NYSEMKT:SYN), Oncothyreon (NASDAQ:ONTY)

Equities research analysts at Deutsche Bank assumed coverage on shares of Arrowhead Research Corp (NASDAQ:ARWR) in a research note issued to investors on Wednesday, TheFlyOnTheWall.com reports. The firm set a “buy” rating and a $45.00 price target on the stock. Arrowhead Research Corp (NASDAQ:ARWR) stock performance was 24.46% in last session and finished the day at $26.31. Traded volume was 7,684,553 million shares in the … Continue reading Biotech Gainers: Arrowhead Research (NASDAQ:ARWR), DARA Biosciences (NASDAQ:DARA), Synthetic Biologics (NYSEMKT:SYN), Oncothyreon (NASDAQ:ONTY)

Mark DeFrance03/0603/06

Best Stocks: General Motors Company (NYSE:GM), Arrowhead Research Corp. (NASDAQ:ARWR), Emergent BioSolutions, Inc. (NYSE:EBS), Taiwan Semiconductor Manufacturing (NYSE:TSM), NCI Building Systems (NYSE:NCS)

General Motors Company (NYSE:GM) is planning to unveil a concept electric vehicle on Monday that can go 200 miles on a single charge. It would be introduced in 2017 and cost about $30,000. General Motors Company (NYSE:GM) belongs to Consumer Goods sector. Its net profit margin is 3.50% and weekly performance is 2.15%. On last trading day company shares ended up $35.59. General Motors Company … Continue reading Best Stocks: General Motors Company (NYSE:GM), Arrowhead Research Corp. (NASDAQ:ARWR), Emergent BioSolutions, Inc. (NYSE:EBS), Taiwan Semiconductor Manufacturing (NYSE:TSM), NCI Building Systems (NYSE:NCS)

Chris Lewis01/1201/14